FI117896B - Uudet sulfonamidit - Google Patents

Uudet sulfonamidit Download PDF

Info

Publication number
FI117896B
FI117896B FI955669A FI955669A FI117896B FI 117896 B FI117896 B FI 117896B FI 955669 A FI955669 A FI 955669A FI 955669 A FI955669 A FI 955669A FI 117896 B FI117896 B FI 117896B
Authority
FI
Finland
Prior art keywords
methoxy
phenoxy
pyridin
alkyl
pyrimidin
Prior art date
Application number
FI955669A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955669A (fi
FI955669A0 (fi
Inventor
Werner Neidhart
Henri Ramuz
Volker Breu
Kaspar Burri
Jean-Marie Cassal
Martine Clozel
Georges Hirth
Bernd-Michael Loeffler
Marcel Mueller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI955669A0 publication Critical patent/FI955669A0/fi
Publication of FI955669A publication Critical patent/FI955669A/fi
Application granted granted Critical
Publication of FI117896B publication Critical patent/FI117896B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bipolar Transistors (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FI955669A 1994-11-25 1995-11-24 Uudet sulfonamidit FI117896B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH355994 1994-11-25
CH355994 1994-11-25
CH284295 1995-10-09
CH284295 1995-10-09

Publications (3)

Publication Number Publication Date
FI955669A0 FI955669A0 (fi) 1995-11-24
FI955669A FI955669A (fi) 1996-05-26
FI117896B true FI117896B (fi) 2007-04-13

Family

ID=25691537

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955669A FI117896B (fi) 1994-11-25 1995-11-24 Uudet sulfonamidit

Country Status (22)

Country Link
EP (1) EP0713875B1 (cs)
JP (1) JP2755565B2 (cs)
KR (1) KR100415030B1 (cs)
AT (1) ATE199905T1 (cs)
AU (1) AU691353B2 (cs)
CA (1) CA2162630C (cs)
CZ (1) CZ289920B6 (cs)
DE (1) DE59509107D1 (cs)
DK (1) DK0713875T3 (cs)
ES (1) ES2156179T3 (cs)
FI (1) FI117896B (cs)
GR (1) GR3036065T3 (cs)
HK (1) HK1012345A1 (cs)
HU (1) HU225112B1 (cs)
IL (1) IL116064A (cs)
MA (1) MA23725A1 (cs)
MY (1) MY119409A (cs)
NO (1) NO307606B1 (cs)
NZ (1) NZ280495A (cs)
PT (1) PT713875E (cs)
RU (1) RU2162084C2 (cs)
TW (1) TW394763B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0826674A4 (en) * 1995-04-03 1998-07-08 Sumitomo Pharma EFFECTIVE PYRIMIDINE DERIVATIVES AS PSYCHOTROPE, AND METHOD FOR THE PRODUCTION THEREOF
ATE267808T1 (de) * 1997-08-19 2004-06-15 Hoffmann La Roche Verfahren zur herstellung von 2,5- disubstituierten pyridinen
TWI284642B (en) 1999-01-18 2007-08-01 Hoffmann La Roche Novel heterocyclic sulfonamides
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
ATE380180T1 (de) * 1999-09-03 2007-12-15 Actelion Pharmaceuticals Ltd Bis-sulfonamiden
HUP0204168A2 (hu) * 1999-12-22 2003-04-28 Actelion Pharmaceuticals Ltd. Butin-diol-származékok, ilyeneket tartalmazó gyógyszerkészítmény és előállítása
WO2001081338A1 (en) * 2000-04-25 2001-11-01 Actelion Pharmaceuticals Ltd Substituted sulfonylaminopyrimidines
US6387915B2 (en) 2000-05-31 2002-05-14 Pfizer Inc. Isoxazole-sulfonamide endothelin antagonists
US6670362B2 (en) 2000-09-20 2003-12-30 Pfizer Inc. Pyridazine endothelin antagonists
ATE312096T1 (de) 2001-12-18 2005-12-15 Neue verbindungen
TWI328007B (en) 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
EP1454625A1 (en) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
CN1930135B (zh) * 2004-03-05 2011-12-28 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3拮抗剂的二氨基嘧啶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW287160B (cs) * 1992-12-10 1996-10-01 Hoffmann La Roche
TW394761B (en) * 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines

Also Published As

Publication number Publication date
MA23725A1 (fr) 1996-07-01
MY119409A (en) 2005-05-31
KR960017644A (ko) 1996-06-17
ES2156179T3 (es) 2001-06-16
IL116064A0 (en) 1996-01-31
ATE199905T1 (de) 2001-04-15
AU691353B2 (en) 1998-05-14
IL116064A (en) 2000-06-29
AU3789595A (en) 1996-05-30
FI955669A (fi) 1996-05-26
EP0713875A1 (de) 1996-05-29
HK1012345A1 (en) 1999-07-30
NO954718L (no) 1996-05-28
TW394763B (en) 2000-06-21
DK0713875T3 (da) 2001-06-11
RU2162084C2 (ru) 2001-01-20
CZ289920B6 (cs) 2002-04-17
CA2162630A1 (en) 1996-05-26
NO954718D0 (no) 1995-11-22
GR3036065T3 (en) 2001-09-28
HU225112B1 (en) 2006-06-28
EP0713875B1 (de) 2001-03-21
CZ308895A3 (en) 1997-07-16
NZ280495A (en) 1996-12-20
FI955669A0 (fi) 1995-11-24
HUT75030A (en) 1997-03-28
JPH08208625A (ja) 1996-08-13
PT713875E (pt) 2001-09-28
KR100415030B1 (ko) 2004-05-17
NO307606B1 (no) 2000-05-02
CA2162630C (en) 2007-05-01
JP2755565B2 (ja) 1998-05-20
DE59509107D1 (de) 2001-04-26
HU9503311D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
FI112944B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sulfonyyliaminopyrimidiinijohdannaisten valmistamiseksi
FI120397B (fi) Uudet sulfonamidit
KR100238366B1 (ko) 설폰아미드 및 이를 함유하는 약제학적 제제
FI117896B (fi) Uudet sulfonamidit
NZ243074A (en) 4-pyrimidinebenzenesulphonamide derivatives; medicaments, intermediates, and preparatory processes thereof
NZ250347A (en) Pyrimidine sulphonamides and pharmaceutical compositions
JP2004517855A (ja) 新規なスルファミド類
EP1137642B1 (en) Bis-sulfonamides
US5837708A (en) Sulphonamides
CA2423351C (en) Novel arylalkane-sulfonamides
CA2416785C (en) Novel arylethene-sulfonamides
PL198815B1 (pl) Pochodne 4-heterocyklilosulfonoamidylo-6-metoksy-5-(2-metoksyfenoksy)-2-pirydylopirymidyny, środek farmaceutyczny, zastosowanie pochodnych 4-heterocyklilosulfonoamidylo-6-metoksy-5-(2-metoksyfenoksy)-2-pirydylopirymidyny, ich wytwarzanie i związki pośrednie
WO2001081335A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2002361033B8 (en) Novel alkansulfonamides as endothelin antagonists
PL185692B1 (pl) Nowe sulfonamidy, sposób ich wytwarzania oraz zawierające je preparaty farmaceutyczne
JPH0959160A (ja) 医薬組成物
WO2002083650A1 (en) Novel sulfonylamino-pyrimidines
EP1322624B1 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
JPH0899961A (ja) ベンゼンスルホンアミド誘導体及びその製法
SA95160410B1 (ar) سلفوناميدات sulphonamides

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117896

Country of ref document: FI

MM Patent lapsed